TrialPloS one

Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.

Masashi Sakuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.